Fycompa

Catalyst Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Jan 5, 2024
Approval ID: ec812ea3-de3a-4271-957c-db8f692d1ae3
Products: 7 registered
Version: 4

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use FYCOMPA safely and effectively. See full prescribing information for FYCOMPA. FYCOMPA(perampanel) tablets, for oral use, CIIIFYCOMPA (perampanel) oral suspension, CIIIInitial U.S. Approval: 2012

Quick Stats

Total Products7

Labelers2

Label Sections28

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.